NCT01390792View on ClinicalTrials.gov

Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis)

CompletedOBSERVATIONAL

Enrollment

622

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

February 28, 2009

Study Completion Date

May 31, 2009

Conditions

Influenza, Human

Interventions

DRUG

Zanamivir hydrate

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY

NCT01390792 - Special Drug Use Investigation for Relenza® (Zanamivir) (Prophylaxis) | Biotech Hunter | Biotech Hunter